Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

In the year 2025, Oryzon Genomics had annual revenue of 10.93M EUR with 48.59% growth. Oryzon Genomics had revenue of 10.93M in the quarter ending December 31, 2025, with 48.59% growth.

• Revenue: 10.93M
• Revenue Growth: +48.59%
• P/S Ratio: 19.92
• Revenue / Employee: 232.65K
• Employees: 47
• Market Cap: 217.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.93M	3.58M	48.59%
Dec 31, 2024	7.36M	-6.83M	-48.15%
Dec 31, 2023	14.19M	-1.51M	-9.60%
Dec 31, 2022	15.70M	5.08M	47.88%
Dec 31, 2021	10.62M	1.09M	11.49%